Financing channel feed – Endpoints News

Financing channel feed

Beacon raises $170M to take on J&J in ocular gene therapy

10 months ago

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

10 months ago

Seeking 'financial flexibility,' Esperion sells European royalty on cholesterol-lowering drugs

10 months ago

Artiva refiles for IPO three years after original plans in a vastly different environment

10 months ago

Immunology biotech Alumis secures $250M in shrunken IPO

11 months ago

One Medical CEO-turned-VC wants startups that are 'disruptive from within the ecosystem'

11 months ago

Exclusive: To develop better cell therapies for solid tumors, a new startup plans to test hundreds of them at once

11 months ago

Longevity investors look to add $200M to the table with new growth fund

11 months ago

With a $372M megaround, Formation Bio looks to in-license 10+ drugs

11 months ago

Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds

11 months ago

Zealand rides obesity wave with $1B raise to advance amylin drug and look for a partner

11 months ago

Exclusive: Cityblock Health investors buy employee shares in tender offer

11 months ago

New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi

11 months ago

Ex-Meta scientists launch EvolutionaryScale with $142M seed round, unveiling next-gen AI model for protein design

11 months ago

Can mRNA be harnessed for gene insertion? Moderna's former chief medical officer has $82M to find out

11 months ago

Grail prepares for public debut, and challenges of going independent, after spinoff from Illumina

11 months ago

Commercial-stage blood cancer biotech files for US dual listing

11 months ago

Schizophrenia biotech LB Pharmaceuticals eyes near-term IPO filing — source

11 months ago

Alumis aims for this year’s third-largest biotech IPO as it readies for Phase 3

11 months ago

Gilead tested an antibody many times. A small biotech salvages it, with $40M and ‘conviction’ elsewhere

11 months ago

iOnctura raises €80M to advance early-stage rare eye cancer treatment

11 months ago

Blank check, please? Three healthcare SPACs reveal their IPO plans

11 months ago

Marea Therapeutics launches with $190M, seeing a 'fixable problem' in a neglected cardiometabolic target

11 months ago

Life sciences investor Decheng Capital targets $700M for fifth fund

11 months ago

First page Previous page 12 13 141516 17 18 Next page Last page